A Review of the Anti-inflammatory Properties of Clindamycin in the Treatment of Acne Vulgaris

被引：0

作者：

Del Rosso, James Q. ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
,10
]}

Schmidt, Nicholas F.

机构：

[1] Valley Hosp, Med Ctr, Las Vegas, NV USA

[2] Allergan Pharmaceut Inc, Irvine, CA USA

[3] Graceway Pharmaceut LLC, Bristol, TN USA

[4] Intendis Inc, Pine Brook, NJ USA

[5] Obagi Med Prod Inc, Long Beach, CA USA

[6] OrthoNeutrogena, Skillman, NJ USA

[7] Ranbaxy Labs Ltd, Gurgaon, Haryana, India

[8] SkinMedica Inc, Carlsbad, CA USA

[9] Stiefel Labs Inc, Coral Gables, FL USA

[10] Triax Pharmaceut LLC, Cranford, NJ USA

来源：

CUTIS | 2010年 / 85卷 / 01期

关键词：

SUBMINIMAL INHIBITORY CONCENTRATIONS; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; NEUTROPHIL CHEMOTACTIC FACTOR; GEL FORMULATION VELAC(R); NECROSIS-FACTOR-ALPHA; PROPIONIBACTERIUM-ACNES; INFLAMMATORY ACNE; STAPHYLOCOCCUS-AUREUS; HUMAN KERATINOCYTES; IN-VITRO;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

This article reviews anti-inflammatory properties of clindamycin, which is often used topically for the management of acne vulgaris, usually in combination with other agents. The efficacy of clindamycin in acne treatment has been shown to be sustained for more than 3 decades. It is likely that anti-inflammatory effects play an important role in the therapeutic activity of topical clindamycin. Cutis. 2010;85:15-24.

引用

页码：15 / 24

页数：10

共 50 条

[21] Systematic review of vascular lasers for the treatment of inflammatory active acne vulgaris
Jafarzadeh, Alireza
Heidari, Sama
Omid, Reza
Goodarzi, Azadeh
LASERS IN MEDICAL SCIENCE, 2025, 40 (01)
[22] Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris
Pazoki-Toroudi, Hamidreza
Nilforoushzadeh, Mohamad Ali
Ajami, Marjan
Jaffary, Fariba
Aboutaleb, Nahid
Nassiri-Kashani, Mansour
Firooz, Alireza
CUTANEOUS AND OCULAR TOXICOLOGY, 2011, 30 (04) : 286 - 291
[23] Management of acne vulgaris: Focus on clindamycin and zinc [Management der acne vulgaris: Fokus auf clindamycin und zink]
Korting H.C.
Schöllmann C.
Der Hautarzt, 2009, 60 (1): : 42 - 47
[24] Management of acne vulgaris: Focus on clindamycin and zinc
Korting, H. C.
Schoellmann, C.
HAUTARZT, 2009, 60 (01): : 42 - 47
[25] Clindamycin phosphate 1% gel in acne vulgaris
Rizer, RL
Sklar, JL
Whiting, D
Bucko, A
Shavin, J
Jarratt, M
ADVANCES IN THERAPY, 2001, 18 (06) : 244 - 252
[26] Antibacterial,Anti-Keratinized and Anti-Inflammatory Effects of the GMP,A Multi-Herb Extraction on Acne Vulgaris
Lu Yina
Wang Guangyin
Xie Hong
Tian Jun
ChinaDetergent&Cosmetics, 2018, 3 (04) : 69 - 76
[27] Clindamycin phosphate 1% gel in acne vulgaris
Ronald L. Rizer
Jerald L. Sklar
David Whiting
Alicia Bucko
Joel Shavin
Michael Jarratt
Advances in Therapy, 2001, 18 : 244 - 252
[28] A Review of Adapalene in the Treatment of Acne Vulgaris
Irby, Cynthia E.
Yentzer, Brad A.
Feldman, Steven R.
JOURNAL OF ADOLESCENT HEALTH, 2008, 43 (05) : 421 - 424
[29] Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris
Khodaeiani, Effat
Fouladi, Rohollah Fadaei
Amirnia, Mehdi
Saeidi, Majid
Karimi, Elham Razagh
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2013, 52 (08) : 999 - 1004
[30] Genistein: A Review on its Anti-Inflammatory Properties
Goh, Yu Xian
Jalil, Juriyati
Lam, Kok Wai
Husain, Khairana
Premakumar, Chandini Menon
FRONTIERS IN PHARMACOLOGY, 2022, 13

← 1 2 3 4 5 →